Home Other Building Blocks 7-((4'-Cyano-[1,1'-biphenyl]-4-yl)oxy)-N-hydroxyheptanamide

7-((4'-Cyano-[1,1'-biphenyl]-4-yl)oxy)-N-hydroxyheptanamide

CAS No.:
191228-04-3
Catalog Number:
AG002F4R
Molecular Formula:
C20H22N2O3
Molecular Weight:
338.4003
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG002F4R
Chemical Name:
7-((4'-Cyano-[1,1'-biphenyl]-4-yl)oxy)-N-hydroxyheptanamide
CAS Number:
191228-04-3
Molecular Formula:
C20H22N2O3
Molecular Weight:
338.4003
MDL Number:
MFCD17215384
IUPAC Name:
7-[4-(4-cyanophenyl)phenoxy]-N-hydroxyheptanamide
InChI:
InChI=1S/C20H22N2O3/c21-15-16-6-8-17(9-7-16)18-10-12-19(13-11-18)25-14-4-2-1-3-5-20(23)22-24/h6-13,24H,1-5,14H2,(H,22,23)
InChI Key:
DWIYBCKFYUQVLU-UHFFFAOYSA-N
SMILES:
ONC(=O)CCCCCCOc1ccc(cc1)c1ccc(cc1)C#N
UNII:
R198471H35
Properties
Complexity:
430  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
338.163g/mol
Formal Charge:
0
Heavy Atom Count:
25  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
338.407g/mol
Monoisotopic Mass:
338.163g/mol
Rotatable Bond Count:
9  
Topological Polar Surface Area:
82.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.6  
Literature
Title Journal
A role for age-related changes in TGFbeta signaling in aberrant chondrocyte differentiation and osteoarthritis. Arthritis research & therapy 20100101
Trifluoromethyl ketones as inhibitors of histone deacetylase. Bioorganic & medicinal chemistry letters 20021202
Transforming growth factor beta mimetics: discovery of 7-[4-(4-cyanophenyl)phenoxy]-heptanohydroxamic acid, a biaryl hydroxamate inhibitor of histone deacetylase. Molecular cancer therapeutics 20020801
Properties